Gaucher Disease: Do I Need Multiple Myeloma Screening?

Yes, if you are an adult with Gaucher disease, you should be regularly screened for multiple myeloma and its precursor conditions ^[1][2]. Because multiple myeloma is virtually nonexistent in childhood, these specific oncology screenings do not apply to pediatric patients ^[1]. Adults living with Gaucher disease have a slightly elevated risk of developing certain blood conditions, including multiple myeloma (a cancer of plasma cells in the blood) and monoclonal gammopathy of undetermined significance (MGUS), which is an early, non-cancerous condition that can sometimes turn into multiple myeloma ^[3][4]. Because of this connection, clinical guidelines recommend regular monitoring—usually through an annual blood test called a serum protein electrophoresis (SPEP) ^[1]. Routine screening allows your medical team to catch any abnormalities long before they become serious and ensure your long-term health is protected ^[2].

Understanding Your Risk

Gaucher disease occurs when your body lacks an enzyme needed to break down certain fatty substances called glycolipids ^[5]. Over time, the buildup of these substances keeps the immune system in a state of constant, low-level activation ^[6].

This chronic immune response forces your body to continuously produce certain white blood cells (B-cells and plasma cells) ^[7][8]. In some patients, this ongoing stimulation can cause plasma cells to grow abnormally, resulting in a condition called MGUS ^[6][3]. While MGUS itself typically does not cause symptoms and is not cancer, it requires careful observation because it can eventually develop into multiple myeloma ^[4]. Knowing that this risk exists means you and your care team can stay one step ahead of it.

How the Screening Works

Screening for multiple myeloma and MGUS is a straightforward process that does not require invasive procedures like a bone marrow biopsy unless blood tests indicate a problem first.

The standard of care relies on monitoring the proteins in your blood ^[1]:

• Serum Protein Electrophoresis (SPEP): This is the most common screening tool used. It is a simple blood test that measures the types of protein in the fluid part of your blood. It specifically looks for an “M-protein” (monoclonal protein), an abnormal protein produced by unusual plasma cells.
• Serum Free Light Chain (sFLC) Assay: Sometimes used alongside SPEP, this blood test checks for smaller pieces of these abnormal proteins.
• Immunofixation (IFE): If an abnormal protein is found, this test helps identify its exact type.

When and How Often?

For adults with Gaucher disease, monitoring should happen regularly, regardless of whether you are actively receiving enzyme replacement therapy (ERT) or substrate reduction therapy (SRT) ^[2]. While these therapies successfully reduce lipid buildup, they may not completely reverse the long-term immune activation ^[2][6].

• Routine Checks: An SPEP is typically performed once a year as part of your comprehensive Gaucher disease checkup.
• Symptom-Driven Checks: If you develop unexplained or new symptoms like deep bone pain, unusual fatigue, new anemia, or kidney issues, your doctor might order these tests sooner ^[1][9]. Because bone pain, fatigue, and anemia are also classic symptoms of Gaucher disease itself, it is important to pay attention to symptoms that feel different or worse than your usual baseline ^[1]. Utilizing these specific blood tests helps your doctor precisely distinguish between a routine Gaucher flare-up and a new hematological issue ^[1].

What Happens if the Screen is Abnormal?

If your SPEP results show an abnormal M-protein, it does not automatically mean you have multiple myeloma. In most cases, it indicates MGUS ^[3]. If MGUS is found, your doctor will likely refer you to a hematologist (a blood specialist) and adjust your screening schedule to monitor your blood more frequently ^[1]. Treating the underlying Gaucher disease remains critical, but it does not replace the need for this specialized oncology screening.